NASDAQ: CYTK · Biotechnology
Over the past week, Cytokinetics (CYTK) pulled in 10 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 9% bullish across the tracked sources. Wall Street is more constructive, with 20 of 22 analysts rating CYTK a buy.
There is little buzz around CYTK this week and broad agreement on direction, which is why it reads as a Sell.
Wall Street’s 91% buy share sits next to a crowd that ranges from X at 0% to News at 17%. No other tracker puts the two side by side.
22 analysts have weighed in: a Strong Buy consensus: 20 buy calls against 0 sell, with an average 12-month price target of $108.85.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is cooling and the 2 sources only partly agree, so the read is a Sell.
Analysts sit 82 points above the crowd average of 9%, the professionals are more constructive than retail. The split is inside the crowd: News reads 17% bullish while X sits at 0%, a 17-point spread that single-source trackers miss.
Over the 30-day window, Cytokinetics (CYTK) buzz held subdued around 21.7 while the price drifted down 7.5% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.9M shares. Updated Aug 15, 2026. Over the last 7 trading days, CYTK lost 8.9%. Buzz activity in the recent week averaged 26.4 and was variable, swinging between 17.5 and 52.4. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 10 of the 17 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Reddit data for this stock this week.
No Polymarket data for this stock this week.
Query sentiment for CYTK and 2000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live CYTK sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 15, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (20 / 2 / 0) |
| Crowd bullish (7d) | 9% |
| Avg price target | $108.85 |
| Most bullish source | News, 17% |
| Most bearish source | X, 0% |
| Sentiment spread | 17 pts |
| Mentions (7d) | 10 |
| Market cap | $10.31B |
| P/E · Forward P/E | n/a · 117.7 |
| EPS · Beta | -$7.22 · 0.4 |
| Revenue (TTM) | $67.7M · 0% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from X and News sources, Cytokinetics (CYTK) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 9% bullish across 2 active sources. Those sources contribute 10 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
The crowd reads bearish on Cytokinetics (CYTK), averaging 9% bullish across 2 tracked sources over the last 7 days. The two ends of the range are News at 17% bullish and X at 0%, a 17-point spread. On the professional side, 20 of 22 analysts rate CYTK a buy.
Of the 22 analysts covering Cytokinetics (CYTK), 20 rate it a buy, 2 a hold and 0 a sell, for a strong buy consensus. The average price target is $108.85. That puts the street ahead of the crowd, which averages 9% bullish.
Cytokinetics (CYTK)'s cross-source average is bearish at 9% bullish. All 2 tracked sources lean bearish. News reads 17% bullish and x coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Cytokinetics (CYTK) at 9% bullish. All 2 tracked sources lean bearish. The most bearish reading is x at 0% bullish. 3-day activity momentum is falling across News. The sell signal carries 93/100 conviction.
News is the dominant discussion channel with 6 mentions (60% of total volume). X contributes 4 mentions. The cross-source average is bearish at 9% bullish. All 2 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. CYTK's sell signal at 93/100 conviction reflects a bearish cross-source average at 9% bullish. All 2 tracked sources lean bearish. It is a research shortcut, not financial advice.
The CYTK sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key